Chairman's messageCorporate strategyCompany's boards Board of DirectorsExecutive BoardCurrently selectedSupervisory Board Company informationOur History Executive Board Mr Erik Bogsch (1947) Chairman of the Company's Board of Directors. Responsible for Commercial, International and Governmental Affairs since November 1, 2017. Chemical engineer, qualified economic engineer. With Richter since 1970 in a number of Research and Development management positions. Medimpex director in Mexico from 1977 to 1983. Managing Director of Medimpex UK from 1988 to 1992. Member of the Board of MAGYOSZ, Chairman between 2006 and 2016. Chief Executive Officer of Gedeon Richter from 1992 to November 2017.Mr Gábor Orbán (1979) Appointed Chief Executive Officer from November 1, 2017. Began his professional career as an economist for the National Bank of Hungary and the European Central Bank. He later joined Aegon Asset Management where he worked as a fund manager and the head of the fixed income desk. He served as the state secretary in charge of taxation and the financial sector at the Minisrty for National Economy for two and a half years, followed by a year spent at Banque Rothschild where he worked as a consultant. He earned is MA degree at the Budapest University of Economics and studied also in the United States. Richter's Director of Corporate Strategy since September 2016, Chief Operating Officer since 2017. Member of the Company's Board of Directors from April 2017.Dr Gábor Gulácsi (1958) Appointed Deputy Managing Director upon joining the Company in 2000. Responsible for Finance. Economist, University doctorate in Economic Sciences. Previously General Secretary of State, Ministry of Economic Affairs. Dr István Greiner (1960) Appointed Research Director in 2014. Chemical engineer (M.Sc), a qualified patent attorney, has a PhD and an MBA degree (Open University, UK). Joined Richter in 1984 and has held a number of management positions including Head of Chemical R&D, Head of the Patent Department between 1996 and 1999. In 2001 he was appointed Deputy to the Research Director and from 2006 he also became responsible for the new recombinant biotechnological activity of the Company.Mr Tibor Horváth (1974) Appointed Commercial Director in 2017. Has an MSc in Biology and Chemisty and an MBA in Marketing and International Commerce. Joined Richter in 1999 as a market analyst then worked as a licensing manager. In 2005 he was appointed Managing Director of Richter's German subsidiary Gedeon Richter Pharma GmbH, where he worked until August 2017. Dr György Thaler (1959) Appointed Development Director in 1993. Chemical engineer, University doctorate in Chemical Sciences. With Richter since 1983 in a number of management positions.
Mr Erik Bogsch (1947) Chairman of the Company's Board of Directors. Responsible for Commercial, International and Governmental Affairs since November 1, 2017. Chemical engineer, qualified economic engineer. With Richter since 1970 in a number of Research and Development management positions. Medimpex director in Mexico from 1977 to 1983. Managing Director of Medimpex UK from 1988 to 1992. Member of the Board of MAGYOSZ, Chairman between 2006 and 2016. Chief Executive Officer of Gedeon Richter from 1992 to November 2017.
Mr Gábor Orbán (1979) Appointed Chief Executive Officer from November 1, 2017. Began his professional career as an economist for the National Bank of Hungary and the European Central Bank. He later joined Aegon Asset Management where he worked as a fund manager and the head of the fixed income desk. He served as the state secretary in charge of taxation and the financial sector at the Minisrty for National Economy for two and a half years, followed by a year spent at Banque Rothschild where he worked as a consultant. He earned is MA degree at the Budapest University of Economics and studied also in the United States. Richter's Director of Corporate Strategy since September 2016, Chief Operating Officer since 2017. Member of the Company's Board of Directors from April 2017.
Dr Gábor Gulácsi (1958) Appointed Deputy Managing Director upon joining the Company in 2000. Responsible for Finance. Economist, University doctorate in Economic Sciences. Previously General Secretary of State, Ministry of Economic Affairs.
Dr István Greiner (1960) Appointed Research Director in 2014. Chemical engineer (M.Sc), a qualified patent attorney, has a PhD and an MBA degree (Open University, UK). Joined Richter in 1984 and has held a number of management positions including Head of Chemical R&D, Head of the Patent Department between 1996 and 1999. In 2001 he was appointed Deputy to the Research Director and from 2006 he also became responsible for the new recombinant biotechnological activity of the Company.
Mr Tibor Horváth (1974) Appointed Commercial Director in 2017. Has an MSc in Biology and Chemisty and an MBA in Marketing and International Commerce. Joined Richter in 1999 as a market analyst then worked as a licensing manager. In 2005 he was appointed Managing Director of Richter's German subsidiary Gedeon Richter Pharma GmbH, where he worked until August 2017.
Dr György Thaler (1959) Appointed Development Director in 1993. Chemical engineer, University doctorate in Chemical Sciences. With Richter since 1983 in a number of management positions.
Horváth Tibor () 2017 augusztusa óta a Társaság kereskedelmi igazgatója. Biológia-kémia szakos diplomáját az ELTE-n szerezte. 1999-ben lépett be a Richterbe, ahol piacelemzőként majd licensz menedzserként dolgozott. 2003-ban MBA diplomát szerzett (Case Western Reserve University). 2005 májusától 2017-ig a Gedeon Richter Pharma GmbH német kereskedelmi leányvállalat ügyvezető igazgatója.
Dr. Thaler György () 1993-tól a Richter Gedeon fejlesztési igazgatója. Vegyészmérnök, műszaki egyetemi doktor. 1983 óta dolgozik a Társaságnál, ez idő alatt különböző vezető pozíciókat töltött be.
Dr. Greiner István () 2014-től a Társaság kutatási igazgatója. Vegyészmérnök, okleveles szabadalmi ügyvivő, a kémiai tudomány kandidátusa, az angliai Open University MBA fokozatával is rendelkezik. 1984 óta a Richter Gedeon Nyrt.-nél dolgozik, kezdetben mint kutató vegyész, majd mint a kémiai K+F vezetője. 1996 és 1999 között a Szabadalmi osztály vezetését is ellátta. 2001-től a Kutatási igazgató helyettese, ebben a pozícióban volt felelős 2006-tól kezdve a Társaság biotechnológiai tevékenységeinek kialakításáért is.
Orbán Gábor () 2017. november 1-től a Társaság vezérigazgatója. Karrierjét az MNB és az EKB közgazdászaként kezdte, később az Aegon Befektetési Alapkezelő portfólió-menedzsereként és kötvényüzletág-vezetőjeként dolgozott. Két és fél éven keresztül a Nemzetgazdasági Minisztérium adó-és pénzügyekért felelős államtitkára volt, majd 2015. szeptembertől a Rothschild párizsi bankjánál dolgozott. Tanulmányait a Budapesti Közgazdaságtudományi Egyetemen, valamint az Egyesült Államokban végezte. 2016 szeptemberétől a Richter stratégiai igazgatója, 2017. január 1-től általános vezérigazgató-helyettes. 2017 áprilisától tagja az Igazgatóságnak.
Dr. Gulácsi Gábor () 2000 óta a Richter Gedeon Nyrt. kinevezett gazdasági vezérigazgató-helyettese. Közgazdász, közgazdász doktor. Korábban a Gazdasági Minisztérium államtitkára volt. 2010 óta az Igazgatóság tagja.
Bogsch Erik () A Társaság Igazgatóságának elnöke. 2017. november 1-től felelős a kereskedelemért, a nemzetközi és kormányzati kapcsolatokért. Vegyészmérnök, okleveles mérnök-közgazdász. 1970 és 1977 között a kutatás-fejlesztés területén töltött be különböző pozíciókat a Társaságnál. 1977 és 1983 között a Medimpex irodavezetője Mexikóban. 1988 és 1992 között a Medimpex UK ügyvezető igazgatója. A MAGYOSZ elnökségi tagja, 2006-2016 között a MAGYOSZ elnöke. 1992-től 2017 novemberéig a Richter Gedeon vezérigazgatója.